Dimensional Fund Advisors LP increased its position in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 2.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,396,095 shares of the technology company's stock after acquiring an additional 106,044 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.47% of Koninklijke Philips worth $111,662,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of PHG. Choreo LLC boosted its holdings in shares of Koninklijke Philips by 4.6% in the 1st quarter. Choreo LLC now owns 14,530 shares of the technology company's stock valued at $369,000 after purchasing an additional 633 shares during the last quarter. Allworth Financial LP boosted its holdings in shares of Koninklijke Philips by 16.2% in the 1st quarter. Allworth Financial LP now owns 4,638 shares of the technology company's stock valued at $115,000 after purchasing an additional 645 shares during the last quarter. Assetmark Inc. boosted its holdings in shares of Koninklijke Philips by 1.7% in the 1st quarter. Assetmark Inc. now owns 59,806 shares of the technology company's stock valued at $1,519,000 after purchasing an additional 982 shares during the last quarter. US Bancorp DE boosted its holdings in shares of Koninklijke Philips by 0.9% in the 1st quarter. US Bancorp DE now owns 109,831 shares of the technology company's stock valued at $2,790,000 after purchasing an additional 1,014 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Koninklijke Philips by 1.1% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 100,140 shares of the technology company's stock valued at $2,544,000 after purchasing an additional 1,137 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Koninklijke Philips presently has a consensus rating of "Buy".
Check Out Our Latest Stock Analysis on PHG
Koninklijke Philips Trading Down 0.4%
Shares of PHG stock traded down $0.12 during mid-day trading on Thursday, reaching $27.57. The company's stock had a trading volume of 456,557 shares, compared to its average volume of 874,290. The company's 50 day simple moving average is $25.65 and its 200-day simple moving average is $25.03. Koninklijke Philips N.V. has a 12-month low of $21.48 and a 12-month high of $32.91. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $26.54 billion, a PE ratio of 145.09, a price-to-earnings-growth ratio of 0.75 and a beta of 0.75.
Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.12. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. The business had revenue of $5.05 billion for the quarter, compared to the consensus estimate of $4.35 billion. On average, research analysts predict that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.
Koninklijke Philips Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.